Madhukar Hormones & Steroids Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.20 M
- Company Age 15 Year,
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.40 Cr
- Revenue Growth %
- Profit Growth 16.44%
- Ebitda
- Net Worth -158.93%
- Total Assets -4.32%
About Madhukar Hormones & Steroids
Madhukar Hormones & Steroids Private Limited (MHSPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 February 2010 and has a history of 15 years. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.20 M.
The company has closed loans amounting to ₹1.40 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100MH2010PTC199609
-
Company No.
199609
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
03 Feb 2010
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Madhukar Hormones & Steroids?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prasad Chodankar
|
Director | 03-Feb-2010 | Current |
|
Sandhya Chodankar
|
Director | 25-Jun-2024 | Current |
Financial Performance of Madhukar Hormones & Steroids.
Madhukar Hormones & Steroids Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 16.44% increase in profit. The company's net worth observed a substantial decline by a decrease of 158.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Madhukar Hormones & Steroids?
In 2017, Madhukar Hormones & Steroids had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Hegenlife Remedies Private LimitedPrasad Chodankar is a mutual person
-
Dr.Madhukar Pharmaceuticals Private LimitedPrasad Chodankar and Sandhya Chodankar are mutual person
Charges (Loans)
₹0
₹14.00 M
Charges Breakdown by Lending Institutions
- Nkgsb Co-Op. Bank Ltd. : 1.40 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Nov 2011 | Nkgsb Co-Op. Bank Ltd. | ₹1.40 Cr | Satisfied |
How Many Employees Work at Madhukar Hormones & Steroids?
Unlock and access historical data on people associated with Madhukar Hormones & Steroids, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Madhukar Hormones & Steroids, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Madhukar Hormones & Steroids's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
